Register below to join thousands of GPs around Australia using CloudHolter to efficiently and confidently manage their patient's cardiac care. We'd also like to invite you to consider joining our journey as a shareholder.

​

While CloudHolter is primarily known as an innovative, in-practice Holter monitoring service, behind the scenes, we're pioneering the development of cutting-edge, Artificial Intelligence (AI) software to diagnose heart rhythm issues.

​

CloudHolter has an impressive track record of strong, consistent growth and we're preparing for an IPO on the Australian Stock Exchange (ASX) with the support of Morgans, Australia's largest, full-service stockbroking and wealth management network.

​

We recognise the support we receive from our extensive network of referring GPs and would like our GP partners to share in our success, rather than just reading about it in the Australian Financial Review!

As such, we’ve adopted a capital-raising strategy that offers our GP partners very attractive investment terms to join our journey as shareholders. We believe there’s potential for a substantial return and no minimum investment is required.

​

By referring and investing in CloudHolter, you're contributing to advancing cardiac healthcare in Australia and will also share in the global opportunity of the AI software that we're developing.

​

Register your interest below and we'll contact you to discuss next steps.